COVID-19

Scientific Publications

PMID: 27521362
Title: A Phase 1 Study of 4 Live Recombinant Human Cytomegalovirus Towne Toledo Chimera Vaccines in Cytomegalovirus Seronegative Men
Abstract:  Human cytomegalovirus (HCMV) infection causes disease in newborns and transplant recipients. A HCMV vaccine (Towne) protects transplant recipients.
Date: 1970-08-22
Year: 2017
Journal: J. Infect. Dis.
PMID Author: Adler SP, Manganello AM, Lee R, McVoy MA, Nixon DE, Plotkin S, Mocarski E, Cox JH, Fast PE, Nesterenko PA, Murray SE, Hill AB, Kemble G
PMC Link #: PMC5079366

A Phase 1 Study of 4 Live Recombinant Human Cytomegalovirus Towne Toledo Chimera Vaccines in Cytomegalovirus Seronegative Men

A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men. J. Infect. Dis. 2016;214(9):1341-1348

Media Contacts

Africa

Ethel Makila
+254 71 904 3142
EMakila@iavi.org 

 

Europe

Hester Kuipers
+31 20 521 0343
HKuipers@iavi.org 

 

India

Devi Leena Bose
+91 11 4737 6031
DLeena@iavi.org 

 

North America

Rose Catlos
+1 212 847 1049
RCatlos@iavi.org